Alternative source for anti-cancer drug identified

They have developed an economically-efficient method of production

February 26, 2021 01:45 am | Updated 01:45 am IST - CHENNAI

Researchers at the Indian Institute of Technology-Madras have identified a sustainable, high-yielding alternative source for the anti-cancer drug camptothecin.

Camptothecin is an alkaloid isolated from ‘Camptotheca Acuminata’, a Chinese tree and ‘Nothapodytes Nimmoniana’, an Indian tree. It requires nearly 1,000 tonnes of plant material to extract one tonne of camptothecin. In the past decade, the population of N. Nimmoniana fell by 20%, according to the researchers.

The researchers have developed a microbial fermentation process that can be an economically-efficient method of production to fulfil the market demand.

Two drugs, topotecan and irinotecan, are produced using camptothecin.

Over a dozen derivatives of camptothecin are under various stages of clinical trials.

Smita Srivastava, associate professor in the Department of Biotechnology, led the research.

Ms. Srivastava, the principal investigator of the study said, “The novelty of the work lies in the fact that unlike other potential microbial strains reported, this strain has been found to show sustainable production even beyond 100 generations. The plan now is to use the isolated novel strain to develop a microbial fermentation-based sustainable bioprocess for large-scale in vitro production of camptothecin, preferably in collaboration with interested industrial partners,” she said.

There are five members on her team, including a researcher from the University of Agricultural Sciences, GKVK, Bengaluru.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.